KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Estee Lauder Companies (EL) Asset Writedowns and Impairment (2018 - 2025)

Estee Lauder Companies (EL) has 10 years of Asset Writedowns and Impairment data on record, last reported at $425.0 million in Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment fell 9.77% year-over-year to $425.0 million; the TTM value through Jun 2025 reached $1.8 billion, up 273.04%, while the annual FY2025 figure was $1.3 billion, 173.04% up from the prior year.
  • Asset Writedowns and Impairment reached $425.0 million in Q2 2025 per EL's latest filing, down from $861.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $861.0 million in Q4 2024 and bottomed at $25.0 million in Q2 2022.
  • Average Asset Writedowns and Impairment over 4 years is $289.0 million, with a median of $211.5 million recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 90.46% in 2021, then skyrocketed 554.55% in 2022.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $74.0 million in 2021, then skyrocketed by 179.73% to $207.0 million in 2022, then surged by 315.94% to $861.0 million in 2024, then crashed by 50.64% to $425.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $425.0 million in Q2 2025, $861.0 million in Q4 2024, and $471.0 million in Q2 2024.